| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An operational model for GPCR homodimers and its application in the analysis of biased signaling
|
Zhou, Bin
|
|
2018
|
23 |
9 |
p. 1591-1595
|
article
|
| 2 |
Applying the 3Rs to neuroscience research involving nonhuman primates
|
Lemon, Roger N.
|
|
2018
|
23 |
9 |
p. 1574-1577
|
article
|
| 3 |
Bioinformatics-based tools in drug discovery: the cartography from single gene to integrative biological networks
|
Ramharack, Pritika
|
|
2018
|
23 |
9 |
p. 1658-1665
|
article
|
| 4 |
Bioorthogonal chemistry in bioluminescence imaging
|
Godinat, Aurélien
|
|
2018
|
23 |
9 |
p. 1584-1590
|
article
|
| 5 |
Contents page 1
|
|
|
2018
|
23 |
9 |
p. i
|
article
|
| 6 |
Contents page 2
|
|
|
2018
|
23 |
9 |
p. ii
|
article
|
| 7 |
Drug testing and characterization using human-on-chip (HoC) systems: some thoughts on the application of in vitro–in vivo correlation
|
Somayaji, Mahadevabharath R.
|
|
2018
|
23 |
9 |
p. 1571-1573
|
article
|
| 8 |
Host-defense peptides and their potential use as biomarkers in human diseases
|
Silva, Osmar N.
|
|
2018
|
23 |
9 |
p. 1666-1671
|
article
|
| 9 |
Interrogating the microbiome: experimental and computational considerations in support of study reproducibility
|
Poussin, Carine
|
|
2018
|
23 |
9 |
p. 1644-1657
|
article
|
| 10 |
Lipid–polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions
|
Garg, Neeraj K.
|
|
2018
|
23 |
9 |
p. 1610-1621
|
article
|
| 11 |
Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies
|
Pavan, Barbara
|
|
2018
|
23 |
9 |
p. 1672-1679
|
article
|
| 12 |
Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes
|
Tripathi, Manish K.
|
|
2018
|
23 |
9 |
p. 1635-1643
|
article
|
| 13 |
The inherent risks associated with newly traded biopharmaceutical firms
|
Williams, David R.
|
|
2018
|
23 |
9 |
p. 1680-1688
|
article
|
| 14 |
Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory
|
Morgentin, Remy
|
|
2018
|
23 |
9 |
p. 1578-1583
|
article
|
| 15 |
U-BIOPRED: evaluation of the value of a public–private partnership to industry
|
Riley, John H.
|
|
2018
|
23 |
9 |
p. 1622-1634
|
article
|
| 16 |
When fragments link: a bibliometric perspective on the development of fragment-based drug discovery
|
Romasanta, Angelo K.S.
|
|
2018
|
23 |
9 |
p. 1596-1609
|
article
|
Journal description